Aster Dm Healthcare Ltd. · NSE:ASTERDM

Aster Dm Healthcare — Q1 FY20 Earnings Presentation

36 slides from Aster Dm Healthcare's earnings presentation, Aug 7, 2019

  1. Slide 1: Cover letter to stock exchanges

    7 August 2019 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Sc

  2. Slide 2: Investor Presentation – For the quarter ended 30th June 2019

    ASTER OM HEALTHCARE Investor Presentation – For the quarter ended 30th June-2019 www.asterdmhealthcare.com1

  3. Slide 3: Disclaimer

    I I Disclaimer  This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other co

  4. Slide 4: Aster – Snapshot, Evolution and Footprint

    I I Aster – Snapshot, Evolution and Footprint ~ I Aster – An Integrated Healthcare Provider Operational and Financial Overview ) Strategy and Leadership 3

  5. Slide 5: Geographical Footprint

    I Geographical Footprint I GCC INDIA Hospitals – 12 Clinics – 107 Hospitals - 13 Pharmacies - 231 Clinics - 8 United Arab Emirates Kerala • Medcare Hospital, Dubai • Aster Medcity, Kochi • Medcare Orthopaedics and Spine Hospital • Aster MIMS, Calicut • Aster Hospital Mankhool • Aster MIMS, Kottakkal

  6. Slide 6: Aster DM Healthcare – At a Glance (1/2)

    I I Aster DM Healthcare – At a Glance (1/2) One of Largest Private CAPACITY BEDS HOSPITALS healthcare service providers GCC: 1,101 GCC: 12 4,794 25 India: 3,693 India: 13 operating in Asia (GCC & India) PATIENT VISITS – FY20Q1 Present in 9 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, GCC: ~4.1

  7. Slide 7: Aster DM Healthcare – At a Glance (2/2)

    Aster DM Healthcare – At a Glance (2/2) I I Revenue - FY20Q1 Revenue - FY20Q1 India 18% Pharmacies GCC INR ~2,029 Cr ._____> 26% Clinics Hospitals 51% 23% 82% EBITDA - FY20Q1 EBITDA - FY20Q1 India Pharmacies 16% 16% <.....---------- INR ~164 Cr .....____> Clinics 27% Hospitals GCC 57% 84% Note: 1. R

  8. Slide 8: Aster DM – A Healthcare Ecosystem

    I I The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder Differentiated Asset-light Business Model in GCC struc

  9. Slide 9: Aster DM Healthcare – Evolution

    I I Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 1987: Commenced 2003: Expansion to new geogr

  10. Slide 10: Robust Growth Over Last 5 Years

    I ROBUST GROWTH OVER LAST 5 YEARS I Outpatient Count (in mn) Inpatient Count (in '000) Aster DM - Revenue from Operations (INR Cr) 8.7 7.8 218 6.7 202 7,963 5.6 158 6,721 5,931 4.2 125 5,250 3.4 104 3,876 2.2 85 2,871 2.1 2.2 52 58 2,029 1,775 - - - - - - - - - - - - FY14 FY15 FY16 FY17 FY18 FY19 FY

  11. Slide 11: Aster – An Integrated Healthcare Provider

    I I Aster – Snapshot, Evolution and Footprint ~ I Aster – An Integrated Healthcare Provider Operational and Financial Overview ) Strategy and Leadership 10

  12. Slide 12: FY19 Operational Information

    I I Aster - An Integrated Healthcare Provider FY19 Operational Information 1,700+ 2,18,000+ Cardiovascular IP Discharges Surgeries ~5.6 mn 14,800+ 500+ Clinic OPD Visits General Bariatric ■ /E)\ Surgeries Surgeries Clinics $ 1 ₹6 0% 1200+ Joint I ----- - PRIMARY ~ 9.6 mn Pharmacy Visits Replacements

  13. Slide 13: Aster – A Healthcare Ecosystem

    I I Aster – A Healthcare Ecosystem PATIENT LIFE CYCLE MANAGEMANT  Aster, over 30 years, has created a healthcare eco-system across two geographical regions  In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient i·" journey, while pharmacies and hospitals ......

  14. Slide 14: GCC Healthcare – Unique Traits

    I I GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat Population (mn) and working age population Expat% -> ~80% ~70% ~45% ~30% Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) 32.0  Due to lower % of

  15. Slide 15: Aster – Awards & Service Excellence

    I I Aster - Awards & Service Excellence JCI Accreditation for 7 Hospitals Padma Shri Award 1 Clinic and 1 diagnostic centre P.f ".~-11· ..9!' "' ....~ ' . “The Sheikh Khalifa Excellence Award” . (2018) ,r-_ " ... Medcare Hospital Dubai, Medcare "'}, ' Dr. Azad Moopen, Chairman & Orthopaedics and Spi

  16. Slide 16: Operational and Financial Overview

    I I Aster – Snapshot, Evolution and Footprint ~ I Aster – An Integrated Healthcare Provider Operational and Financial Overview ) Strategy and Leadership 15

  17. Slide 17: Key Highlights – FY20 Q1

    I I Key Highlights – FY20 Q1 Clinical and Operational Highlights  Expert team of doctors from Neurology & Infection Control at Aster Medcity, Kochi; managed early detection of Nipah Virus in a patient and successfully treated him with help of doctors and staff in MICU  Sex Reassignment Surgery (Fe

  18. Slide 18: Revenue and Profitability Snapshot – FY20 Q1

    I I Revenue and Profitability Snapshot – FY20 Q1 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) _J₹ 1775 ₹ 2029 _J₹ 124 ₹ 164 ₹ 12 ₹ 18 ,----- y 7.0% 8.1% 0.9% 0.7% FY19 Q1 FY20 Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 Q1  Constant currency growth of Revenue, EBITDA and Adjusted PAT is ~

  19. Slide 19: Business – Snapshot (1/2)

    I I Business – Snapshot (1/2) GCC INDIA CONSOLIDATED FY19 Q1 FY20 Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 Q1 • Total Capacity Beds 887 1,101 3,158 3,693 4,045 4,794 • Operational Beds 769 909 2,141 2,461 2,910 3,370 • ALOS (Days) 2.0 1.9 3.5 3.5 2.9 2.9 • Occupancy4 57% 50% 59% 58% 58% 56% • Outpatient Visi

  20. Slide 20: Business – Snapshot (2/2)

    I I Business – Snapshot (2/2) GCC INDIA CONSOLIDATED FY19 Q1 FY20 Q1 FY19 Q1 FY20 Q1 FY19 Q1 FY20 Q1 Revenue (₹) 1,470 Cr 1,658 Cr 305 Cr 370 Cr 1,775 Cr 2,029 Cr EBITDA (₹) 107 Cr 138 Cr 17 Cr 27 Cr 124 Cr 164 Cr PAT (₹) 23 Cr 29 Cr (11) Cr (11) Cr 12 Cr 18 Cr Notes: 1. Revenue and EBITDA shown abo

  21. Slide 21: Segmental Performance FY20Q1

    I I Segmental Performance FY20Q1 Growth % India - Unallocated India - Unallocated GCC GCC GCC GCC FY20 Q1 GCC Clinics Hospitals & & Total GCC Clinics Hospitals & & Total Hospitals Pharmacies Hospitals Pharmacies Clinics Eliminations Clinics Eliminations No. of Business Units (#) 12 107 231 H-13, C-8

  22. Slide 22: Vintage-wise Performance FY20Q1

    I I Vintage-wise Performance FY20Q1 GCC Hospitals - Revenue (INR Cr) GCC Clinics - Revenue (INR Cr) India Hospitals and Clinics - Consolidated - Revenue (INR Cr)* Revenue (INR Cr) 575 - 113 689 453 30 483 272 - 98 370 1,788 241 2,029 Established Units Ramp-up units Total Established Units Ramp-up un

  23. Slide 23: Hospitals List

    I I Hospitals List C ommenc ement/ Bed Operational Owned Hos pitals - GC C L oc ation Capaci t y Oper at i onal Ac quis ition Year C apac ity Beds /L eas ed Geogr aphy Medcare Hospital Dubai, UAE 2007 64 55 Leased Beds Beds Al Raffa Hospital Muscat, Oman 2009 85 72 Leased GCC 1,101 909 Al Raffa Hosp

  24. Slide 24: Maturity Wise Hospital Performance – GCC FY20Q1

    I I Maturity Wise Hospital Performance – GCC FY20Q1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 16% 28% 0-3 Years 4 ₹ 113.5 250 ₹ ~174,100 30% ₹(3) Over 3 Years 84% 72% ₹ ~173,500 57% ₹86 8 ₹575.1 659 15% 12 ₹ 688

  25. Slide 25: Maturity Wise Hospital Performance – India FY20Q1

    I I Maturity Wise Hospital Performance – India FY20Q1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 26% 23% ₹ (2) 0-3 Years 3 ₹ 95 569 ₹ ~35,100 54% Over 3 Years 74% 77% ₹ ~25,500 60% ₹34 9 ₹271 1892 12.6% 12 ₹ 366

  26. Slide 26: Financial Summary – Profitability Statement (1/2)

    I I Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY19 Q4 FY19 Q1 FY20 Q1 Gw% Revenue from operations 2,201 1,775 2,029 14% ================================================== Material consumption 663 ==================== 552 627 Doctors cost 450 399 465 Employee cost (excl.

  27. Slide 27: Financial Summary – Balance Sheet & Ratios

    I I Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Jun 30, Particulars (INR Cr) 2019 2019 LIABILITIES Shareholders Equity 3,214 3,056 Minority Interest 466 476 Debt 2,672 2,809 Lease Liabilities - INDAS116 - 2,325 Other current and non-current liabilities 2,584 2,510 Total Liabilitie

  28. Slide 28: Financial Summary – INDAS116 Impact

    I I Financial Summary – INDAS116 Impact GCC India Consolidated FY20 Q1 - FY20 Q1 - FY20 Q1 - before before before Particulars (INR Cr) FY19 Q1 INDAS116 INDAS 116 FY20 Q1 FY19 Q1 INDAS116 INDAS 116 FY20 Q1 FY19 Q1 INDAS116 INDAS 116 FY20 Q1 Revenue 1,470.1 1,658.3 1,658.3 304.5 370.3 370.3 1,774.6 2,

  29. Slide 29: Pipeline Projects

    I I Pipeline Projects Expected Completion Owned / Hospitals - GCC Location Type Planned Beds Stage Year Leased/O&M Aster Hospital Sonapur, Dubai, UAE Greenfield 41 Q4 FY 2020 Construction Leased Aster Hospital Sharjah, UAE Greenfield 80 Q4 FY 2020 Construction Leased Greenfield Aster Hospital Muscat

  30. Slide 30: Strategy and Leadership

    I I Aster – Snapshot, Evolution and Footprint ~ I Aster – An Integrated Healthcare Provider Operational and Financial Overview ) Strategy and Leadership 29

  31. Slide 31: ADMHL – Strategy & Outlook (1/2)

    ADMHL – Strategy & Outlook (1/2) I I Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations

  32. Slide 32: ADMHL – Strategy & Outlook (2/2)

    I I ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant

  33. Slide 33: India Strategy

    I I India Strategy India is geographically well positioned for Focus on In line with medical tourism focus on large format from the GCC hospitals in Tier 1 derisking states, MENA business – cities – Hospitals region and South- in Tier 1 cities The new National Health Protection Scheme target of 25%

  34. Slide 34: Aster Leadership Team

    I I Aster Leadership Team Dr. Azad Moopen Dr. Harish Pillai Veneeth Purushotaman Chairman and Managing Director Chief Executive Officer – India Chief Information Officer Alisha Moopen Jobilal M. Vavachan Chief Executive Officer – Chief Executive Officer, Aster Fara Siddiqi GCC Hospitals & Clinics Ph

  35. Slide 35: Aster Board of Directors

    I I Aster Board of Directors strategy andleadership Ravi Prasad Daniel James Dr. Azad Moopen Independent Director Snyder Chairman and Managing Director Independent Director Alisha Moopen M. Madhavan Suresh M. Non-Executive Director Nambiar Kumar Independent Director Independent Director Daniel Rober

  36. Slide 36: Thank You

    JHANK YOU 35 www.asterdmhealthcare.com

Aster DM Healthcare — Q1 FY20 Earnings Presentation on 6ix